443 related articles for article (PubMed ID: 12297057)
1. Airway mucus in cystic fibrosis.
Puchelle E; Bajolet O; Abély M
Paediatr Respir Rev; 2002 Jun; 3(2):115-9. PubMed ID: 12297057
[TBL] [Abstract][Full Text] [Related]
2. CFTR, mucins, and mucus obstruction in cystic fibrosis.
Kreda SM; Davis CW; Rose MC
Cold Spring Harb Perspect Med; 2012 Sep; 2(9):a009589. PubMed ID: 22951447
[TBL] [Abstract][Full Text] [Related]
3. Model of mucociliary clearance in cystic fibrosis lungs.
Kurbatova P; Bessonov N; Volpert V; Tiddens HA; Cornu C; Nony P; Caudri D;
J Theor Biol; 2015 May; 372():81-8. PubMed ID: 25746843
[TBL] [Abstract][Full Text] [Related]
4. Pharmacotherapy of the ion transport defect in cystic fibrosis: role of purinergic receptor agonists and other potential therapeutics.
Kunzelmann K; Mall M
Am J Respir Med; 2003; 2(4):299-309. PubMed ID: 14719996
[TBL] [Abstract][Full Text] [Related]
5. A glycopolymer improves vascoelasticity and mucociliary transport of abnormal cystic fibrosis mucus.
Fernandez-Petty CM; Hughes GW; Bowers HL; Watson JD; Rosen BH; Townsend SM; Santos C; Ridley CE; Chu KK; Birket SE; Li Y; Leung HM; Mazur M; Garcia BA; Evans TIA; Libby EF; Hathorne H; Hanes J; Tearney GJ; Clancy JP; Engelhardt JF; Swords WE; Thornton DJ; Wiesmann WP; Baker SM; Rowe SM
JCI Insight; 2019 Apr; 4(8):. PubMed ID: 30996141
[TBL] [Abstract][Full Text] [Related]
6. Unplugging Mucus in Cystic Fibrosis and Chronic Obstructive Pulmonary Disease.
Mall MA
Ann Am Thorac Soc; 2016 Apr; 13 Suppl 2():S177-85. PubMed ID: 27115954
[TBL] [Abstract][Full Text] [Related]
7. Pathological mucus and impaired mucus clearance in cystic fibrosis patients result from increased concentration, not altered pH.
Hill DB; Long RF; Kissner WJ; Atieh E; Garbarine IC; Markovetz MR; Fontana NC; Christy M; Habibpour M; Tarran R; Forest MG; Boucher RC; Button B
Eur Respir J; 2018 Dec; 52(6):. PubMed ID: 30361244
[TBL] [Abstract][Full Text] [Related]
8. Development of an airway mucus defect in the cystic fibrosis rat.
Birket SE; Davis JM; Fernandez CM; Tuggle KL; Oden AM; Chu KK; Tearney GJ; Fanucchi MV; Sorscher EJ; Rowe SM
JCI Insight; 2018 Jan; 3(1):. PubMed ID: 29321377
[TBL] [Abstract][Full Text] [Related]
9. Mucins and CFTR: Their Close Relationship.
Okuda K; Shaffer KM; Ehre C
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142171
[TBL] [Abstract][Full Text] [Related]
10. Impaired mucus detachment disrupts mucociliary transport in a piglet model of cystic fibrosis.
Hoegger MJ; Fischer AJ; McMenimen JD; Ostedgaard LS; Tucker AJ; Awadalla MA; Moninger TO; Michalski AS; Hoffman EA; Zabner J; Stoltz DA; Welsh MJ
Science; 2014 Aug; 345(6198):818-22. PubMed ID: 25124441
[TBL] [Abstract][Full Text] [Related]
11. Evidence of early increased sialylation of airway mucins and defective mucociliary clearance in CFTR-deficient piglets.
Caballero I; Ringot-Destrez B; Si-Tahar M; Barbry P; Guillon A; Lantier I; Berri M; Chevaleyre C; Fleurot I; Barc C; Ramphal R; Pons N; Paquet A; Lebrigand K; Baron C; Bähr A; Klymiuk N; Léonard R; Robbe-Masselot C
J Cyst Fibros; 2021 Jan; 20(1):173-182. PubMed ID: 32978064
[TBL] [Abstract][Full Text] [Related]
12. Progress in understanding mucus abnormalities in cystic fibrosis airways.
Wine JJ; Hansson GC; König P; Joo NS; Ermund A; Pieper M
J Cyst Fibros; 2018 Mar; 17(2S):S35-S39. PubMed ID: 28951068
[TBL] [Abstract][Full Text] [Related]
13. Modulation of Ion Transport to Restore Airway Hydration in Cystic Fibrosis.
Reihill JA; Douglas LEJ; Martin SL
Genes (Basel); 2021 Mar; 12(3):. PubMed ID: 33810137
[TBL] [Abstract][Full Text] [Related]
14. Cystic fibrosis transmembrane conductance regulator is expressed in mucin granules from Calu-3 and primary human airway epithelial cells.
LeSimple P; Goepp J; Palmer ML; Fahrenkrug SC; O'Grady SM; Ferraro P; Robert R; Hanrahan JW
Am J Respir Cell Mol Biol; 2013 Oct; 49(4):511-6. PubMed ID: 23742042
[TBL] [Abstract][Full Text] [Related]
15. Mucus, mucins, and cystic fibrosis.
Morrison CB; Markovetz MR; Ehre C
Pediatr Pulmonol; 2019 Nov; 54 Suppl 3(Suppl 3):S84-S96. PubMed ID: 31715083
[TBL] [Abstract][Full Text] [Related]
16. Cystic fibrosis: a disease of vulnerability to airway surface dehydration.
Boucher RC
Trends Mol Med; 2007 Jun; 13(6):231-40. PubMed ID: 17524805
[TBL] [Abstract][Full Text] [Related]
17. Mucus aberrant properties in CF: Insights from cells and animal models.
Ehre C; Hansson GC; Thornton DJ; Ostedgaard LS
J Cyst Fibros; 2023 Mar; 22 Suppl 1(Suppl 1):S23-S26. PubMed ID: 36117114
[TBL] [Abstract][Full Text] [Related]
18. Increased airway epithelial Na+ absorption produces cystic fibrosis-like lung disease in mice.
Mall M; Grubb BR; Harkema JR; O'Neal WK; Boucher RC
Nat Med; 2004 May; 10(5):487-93. PubMed ID: 15077107
[TBL] [Abstract][Full Text] [Related]
19. The epithelial sodium channel (ENaC) as a therapeutic target for cystic fibrosis lung disease.
Moore PJ; Tarran R
Expert Opin Ther Targets; 2018 Aug; 22(8):687-701. PubMed ID: 30028216
[TBL] [Abstract][Full Text] [Related]
20. TMEM16A Potentiation: A Novel Therapeutic Approach for the Treatment of Cystic Fibrosis.
Danahay HL; Lilley S; Fox R; Charlton H; Sabater J; Button B; McCarthy C; Collingwood SP; Gosling M
Am J Respir Crit Care Med; 2020 Apr; 201(8):946-954. PubMed ID: 31898911
[No Abstract] [Full Text] [Related]
[Next] [New Search]
